BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 35586626)

  • 1. Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing.
    Park HS; Lee YH; Hong N; Won D; Rhee Y
    Front Endocrinol (Lausanne); 2022; 13():853171. PubMed ID: 35586626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilevel Annotation of Germline MEN1 Variants of Synonymous, Nonsynonymous, and Uncertain Significance in Indian Patients With Sporadic Primary Hyperparathyroidism.
    Kaur G; Bhadada SK; Santra M; Pal R; Sarma P; Sachdeva N; Dhiman V; Dahiya D; Saikia UN; Chakraborty A; Sood A; Prakash M; Behera A; Rao SD
    J Bone Miner Res; 2022 Oct; 37(10):1860-1875. PubMed ID: 35856247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single-center study.
    Song A; Yang Y; Jiang Y; Nie M; Jiang Y; Li M; Xia W; Xing X; Wang O
    J Bone Miner Res; 2023 Sep; 38(9):1322-1333. PubMed ID: 37449924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of Clinical Genetic Testing in Patients with Features Suggestive for Hereditary Predisposition to PTH-Mediated Hypercalcemia.
    Khairi S; Osborne J; Jacobs MF; Clines GT; Miller BS; Hughes DT; Else T
    Horm Cancer; 2020 Oct; 11(5-6):250-255. PubMed ID: 32761341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic testing for familial hyperparathyroidism: clinical-genetic profile in a Mediterranean cohort.
    Mazarico-Altisent I; Capel I; Baena N; Bella-Cueto MR; Barcons S; Guirao X; Pareja R; Muntean A; Arsentales V; Caixàs A; Rigla M
    Front Endocrinol (Lausanne); 2023; 14():1244361. PubMed ID: 37810884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GCM2 Variants in Familial and Multiglandular Primary Hyperparathyroidism.
    Vincze S; Peters NV; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Riccardi A; Parham K; Carling T; Costa-Guda J; Arnold A
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2021-e2026. PubMed ID: 34967908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
    Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
    J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort.
    Mariathasan S; Andrews KA; Thompson E; Challis BG; Wilcox S; Pierce H; Hale J; Spiden S; Fuller G; Simpson HL; Fish B; Jani P; Seetho I; Armstrong R; Izatt L; Joshi M; Velusamy A; Park SM; Casey RT
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):409-418. PubMed ID: 32430905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndrome.
    Mamedova E; Mokrysheva N; Vasilyev E; Petrov V; Pigarova E; Kuznetsov S; Kuznetsov N; Rozhinskaya L; Melnichenko G; Dedov I; Tiulpakov A
    Endocr Connect; 2017 Nov; 6(8):557-565. PubMed ID: 28870973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should the GCM2 gene be tested when screening for familial primary hyperparathyroidism?
    Coppin L; Dufosse M; Romanet P; Giraud S; North MO; Cardot Bauters C; Borson-Chazot F; Duchesne L; Métallo M; Lovecchio T; Barlier A; Odou MF
    Eur J Endocrinol; 2020 Jan; 182(1):57-65. PubMed ID: 31671402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of parathyroid tumours.
    Thakker RV
    J Intern Med; 2016 Dec; 280(6):574-583. PubMed ID: 27306766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent germ-line mutations of the MEN1, CASR, and HRPT2/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism.
    Starker LF; Akerström T; Long WD; Delgado-Verdugo A; Donovan P; Udelsman R; Lifton RP; Carling T
    Horm Cancer; 2012 Apr; 3(1-2):44-51. PubMed ID: 22187299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.
    van der Tuin K; Tops CMJ; Adank MA; Cobben JM; Hamdy NAT; Jongmans MC; Menko FH; van Nesselrooij BPM; Netea-Maier RT; Oosterwijk JC; Valk GD; Wolffenbuttel BHR; Hes FJ; Morreau H
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4534-4540. PubMed ID: 29040582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-Phenotype Correlations in Asian Indian Children and Adolescents with Primary Hyperparathyroidism.
    Sharma A; Memon S; Lila AR; Sarathi V; Arya S; Jadhav SS; Hira P; Garale M; Gosavi V; Karlekar M; Patil V; Bandgar T
    Calcif Tissue Int; 2022 Sep; 111(3):229-241. PubMed ID: 35567607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
    Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
    J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing Genetic Differences Between Sporadic Primary and Secondary/Tertiary Hyperparathyroidism by Targeted Next-Generation Panel Sequencing.
    Hong YA; Park KC; Kim BK; Lee J; Sun WY; Sul HJ; Hwang KA; Choi WJ; Chang YK; Kim SY; Shin S; Park J
    Endocr Pathol; 2021 Dec; 32(4):501-512. PubMed ID: 34215996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism.
    Guan B; Welch JM; Sapp JC; Ling H; Li Y; Johnston JJ; Kebebew E; Biesecker LG; Simonds WF; Marx SJ; Agarwal SK
    Am J Hum Genet; 2016 Nov; 99(5):1034-1044. PubMed ID: 27745835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial Hyperparathyroidism - Disorders of Growth and Secretion in Hormone-Secretory Tissue.
    Marx SJ; Lourenço DM
    Horm Metab Res; 2017 Nov; 49(11):805-815. PubMed ID: 29136674
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Szalat A; Shpitzen S; Pollack R; Mazeh H; Durst R; Meiner V
    Front Endocrinol (Lausanne); 2023; 14():1254156. PubMed ID: 38130397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathogenesis of primary hyperparathyroidism.
    Cetani F; Pardi E; Borsari S; Marcocci C
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.